Early Drug Development/Phase I Program
- New Advancements
Nancy Lewis, MD was co-director of the Phase I program at Fox Chase Cancer Center and Director of the Phase I program at Cooper University Hospital. She joined Thomas Jefferson University in July of this year to develop this new program. She has extensive experience in drug development and also has expertise in gastrointestinal malignancies. She is developing several mechanism based Phase I studies that will go across the division.
Nancy Lewis, MD